  Succinylcholine - Phase I and Phase II Blocks section { margin-bottom: 20px; } table { border-collapse: collapse; } table, tr, th, td { border: 1px solid black; } h3, p, ol.custom-counter, li { margin: 0px; padding: 0px; } .text-red { color: red; } .text-black { color: black; } ul.custom-dash { list-style: none; padding-left: 0; margin: 0; } ul.custom-dash > li { display: flex; align-items: flex-start; } ul.custom-dash > li::before { content: "–"; margin-right: 0.5em; flex-shrink: 0; line-height: 1; } ul.custom-dash > li > \*:not(::before) { flex: 1; } ul.custom-dash > li.no-dash::before { content: ""; width: 1em; margin-right: 0.5em; flex-shrink: 0; } /\* Change the ol style \*/ ol.custom-counter { list-style: none; padding-left: 0; counter-reset: custom calc(var(--start, 1) - 1); } ol.custom-counter li { counter-increment: custom; margin-bottom: 5px; } ol.custom-counter li::before { content: counter(custom) ") "; } /\* This is just for this file \*/ ul.custom-bullet-arrow { list-style: none; padding-left: 0; margin: 0; } ul.custom-bullet-arrow > li { display: flex; align-items: flex-start; } ul.custom-bullet-arrow > li::before { content: "↑"; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet-arrow > li.no-arrow::before { content: ""; width: 0.5em; margin-right: 0.5em; flex-shrink: 0; } ul.custom-bullet\_arrow ul { list-style-type: disc; padding-left: 1.5em; margin-top: 0.5em; } img.resized-200 { width: 200px; height: auto; } img.resized-400 { width: 400px; height: auto; } img.resized-600 { width: 600px; height: auto; } .mb-10px { margin-bottom: 10px; } .mb-20px { margin-bottom: 20px; } .mt-10px { margin-top: 10px; } .mt-20px { margin-top: 20px; } .reference-notes { font-size: 11px; } .text-indent-45px { text-indent: 45px; } .text-bold { font-weight: bold; }

### Succinylcholine (SCh) - Phase I and Phase II Blocks

Phase I and Phase II blocks describe two distinct phases of neuromuscular blockade induced by the depolarizing agent succinylcholine.

**Phase I Block:** It is the typical response to SCh.

**Phase I block:** A prolonged depolarization causing fasciculations and a twitch response that doesn't fade.

**Phase 2 block:** (dual block or desensitization):

-   Phase 2 blocks usually occur from the repeated doses or infusion of SCh.
-   The recovery from succinylcholine generally is prolonged, and the character of the block is altered.
-   Repeat nerve stimulation (train-of-four) is unchanged with repeated stimulation (no fade or decrement of response), and no fade occurs with tetanic stimulation.
-   When a phase II block develops, fade is evident on train-of-four stimulation (T4/T1 less than 50%) and on tetanic stimulation.
-   Post-tetanic potentiation may also be present.
-   These patterns of response are typical of non-depolarizing muscle relaxants, not depolarizing drugs (SCh).
-   The appearance of this block is related to the time and dose of SCh administration.
-   Reports of phase II blocks have been associated with 2–10 mg/kg administered over 1 hour.
-   Inhalation anesthetics may accelerate the onset.

Reversal:

Phase 2 blocks can be reversed with an anticholinesterase drug (neostigmine), but the reversal is often unpredictable.

Stoelting’s Pharmacology & Physiology in Anesthetic Practice 6th Ed, 2022

CH. 12 Neuromuscular-Blocking Drugs and Reversal Agents, pp. 314-318

Pamela Flood, James P. Rathmell

Neuromuscular physiology and pharmacology.

Miller's Anesthesia, 9th edition; 2019:333-353.

by Michael A. Gropper MD PhD (Editor), Lars I. Eriksson MD (Editor), Lee A. Fleisher MD (Editor), Jeanine P. Wiener-Kronish

MD (Editor), Neal H. Cohen MD MPH MS (Editor), Kate Leslie MD (Editor)

Neuromuscular Blockade: Basics

Open Anesthesia 4/2023

Accessed 09/2025

https://www.openanesthesia.org/keywords/neuromuscular-blockade-basics/